Why the study?
Does the timing of low-molecular-weight heparin initiation reduce deep vein thrombosis compared to oral anticoagulants in patients following elective hip arthroplasty?
Population
Patients undergoing elective hip arthroplasty (4 randomized trials)
Comparison
Low-molecular-weight heparin administered at… vs Oral anticoagulants
Design
Systematic_review
Authors
Loading...
Supports perioperative LMWH over oral anticoagulants for DVT prophylaxis after hip arthroplasty; confirms benefit in systematic review of trials.
Does the timing of low-molecular-weight heparin initiation reduce deep vein thrombosis compared to oral anticoagulants in patients following elective hip arthroplasty?
Initiating low-molecular-weight heparin in close proximity to elective hip arthroplasty significantly reduces deep vein thrombosis risk compared to oral anticoagulants without increasing major bleeding.
Hull et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: